HUP9600162A3 - Use of an antagonist of cgrp in cosmetic, pharmaceutical or dermatological compositions and the cosmetic compositions - Google Patents

Use of an antagonist of cgrp in cosmetic, pharmaceutical or dermatological compositions and the cosmetic compositions

Info

Publication number
HUP9600162A3
HUP9600162A3 HU9600162A HUP9600162A HUP9600162A3 HU P9600162 A3 HUP9600162 A3 HU P9600162A3 HU 9600162 A HU9600162 A HU 9600162A HU P9600162 A HUP9600162 A HU P9600162A HU P9600162 A3 HUP9600162 A3 HU P9600162A3
Authority
HU
Hungary
Prior art keywords
cosmetic
compositions
cgrp
antagonist
pharmaceutical
Prior art date
Application number
HU9600162A
Other languages
English (en)
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9475528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9600162(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Publication of HU9600162D0 publication Critical patent/HU9600162D0/hu
Publication of HUP9600162A2 publication Critical patent/HUP9600162A2/hu
Publication of HUP9600162A3 publication Critical patent/HUP9600162A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/225Calcitonin gene related peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14Preparations for removing make-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/002Aftershave preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/004Aftersun preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
HU9600162A 1995-01-26 1996-01-25 Use of an antagonist of cgrp in cosmetic, pharmaceutical or dermatological compositions and the cosmetic compositions HUP9600162A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500900A FR2729855A1 (fr) 1995-01-26 1995-01-26 Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue

Publications (3)

Publication Number Publication Date
HU9600162D0 HU9600162D0 (en) 1996-03-28
HUP9600162A2 HUP9600162A2 (en) 1997-01-28
HUP9600162A3 true HUP9600162A3 (en) 1997-09-29

Family

ID=9475528

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600162A HUP9600162A3 (en) 1995-01-26 1996-01-25 Use of an antagonist of cgrp in cosmetic, pharmaceutical or dermatological compositions and the cosmetic compositions

Country Status (14)

Country Link
US (1) US6019967A (hu)
EP (1) EP0723774B1 (hu)
JP (1) JP3043608B2 (hu)
AR (1) AR002023A1 (hu)
AT (1) ATE197896T1 (hu)
BR (1) BR9600487A (hu)
CA (1) CA2167980C (hu)
DE (1) DE69611106T2 (hu)
DK (1) DK0723774T3 (hu)
ES (1) ES2154388T3 (hu)
FR (1) FR2729855A1 (hu)
HU (1) HUP9600162A3 (hu)
PL (1) PL184701B1 (hu)
RU (1) RU2180854C2 (hu)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
RU2169000C2 (ru) * 1995-09-07 2001-06-20 Л'Ореаль Применение экстракта iridaceae, композиция, содержащая его и способ косметического лечения
BR9712023A (pt) * 1996-09-10 1999-08-31 Thomae Gmbh Dr K Aminoácidos derivados, medicamentos contendo esses compostos e processos para a sua preparação.
US6313097B1 (en) 1999-03-02 2001-11-06 Boehringer Ingelheim Pharma Kg Antagonists of calcitonin gene-related peptide
US7393548B2 (en) * 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
DE19952147A1 (de) 1999-10-29 2001-05-03 Boehringer Ingelheim Pharma Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19958121A1 (de) * 1999-12-02 2001-06-28 Max Planck Gesellschaft Tyrosin- und tryptophanhaltige Peptide als Antioxidantien
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL155097A0 (en) 2000-09-28 2003-10-31 Nanocyte Inc Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US6632420B1 (en) 2000-09-28 2003-10-14 The Gillette Company Personal care product
US7632522B2 (en) * 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
EP1519755B1 (en) * 2002-03-26 2008-05-07 Nanocyte Inc. Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US11517612B2 (en) 2016-11-18 2022-12-06 Nepsone Ehf Methods of treating inflammatory skin disorders
DE60326370D1 (de) 2002-08-12 2009-04-09 Actavis Group Hf Verwendung von cgrp-antagonisten-verbindungen zur behandlung von psoriasis
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
MXPA05004278A (es) * 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20040120915A1 (en) * 2002-12-19 2004-06-24 Kaiyuan Yang Multifunctional compositions for surface applications
EP1452167A1 (de) * 2003-02-28 2004-09-01 Cognis France S.A. Kosmetische, pharmazeutische und/oder dermatologische Zubereitungen enthaltend einen Extrakt aus Eperua falcata
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
CA2610662A1 (en) * 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
AU2007223922B2 (en) * 2006-03-07 2013-05-02 Wilmar Trading Pte Ltd Compositions comprising metathesized unsaturated polyol esters
ES2429407T3 (es) 2006-06-08 2013-11-14 Chugai Seiyaku Kabushiki Kaisha Agente preventivo o remedio para enfermedades inflamatorias
MX2009002536A (es) * 2006-09-08 2009-04-14 Foamix Ltd Composicion espumable coloreada o coloreable y espuma.
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
EP1986473B1 (en) * 2007-04-03 2017-01-25 Tsinghua University Organic electroluminescent device
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
MX2010006097A (es) * 2007-12-05 2010-08-04 Chugai Pharmaceutical Co Ltd Agentes terapeuticos para tratar el prurito.
RU2531521C2 (ru) 2007-12-05 2014-10-20 Чугаи Сейяку Кабусики Кайся Антитело против nr10 и его применение
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
AU2009205314A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011039638A2 (en) 2009-10-02 2011-04-07 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
FR3001391B1 (fr) 2013-01-29 2017-07-07 Oreal Utilisation de cellules vegetales d'iridacee elicitees dans le traitement des peaux sensibles
MA43918A (fr) 2015-04-14 2018-12-05 Chugai Pharmaceutical Co Ltd Composition pharmaceutique pour la prã‰vention et/ou le traitement de la dermatite atopique contenant comme principe actif un antagoniste de l'il-31
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
GB2576208B (en) * 2018-08-10 2023-05-17 Exit Surf Street Summit Ltd Hanger for holding watersport garments
TW202128222A (zh) 2019-11-20 2021-08-01 日商中外製藥股份有限公司 含有抗體之製劑
RU2732295C1 (ru) * 2020-01-10 2020-09-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации Препарат для укрепления и стимулирования роста волос и способ его использования
CN116456981A (zh) * 2020-11-19 2023-07-18 辉瑞爱尔兰制药公司 用于改善的grp抑制剂递送的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2524310A2 (fr) * 1982-04-01 1983-10-07 Olivier Georges Compositions permettant de combattre les mefaits et les inconvenients de la transpiration
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
SE9201425D0 (sv) * 1992-05-06 1992-05-06 Kabi Pharmacia Ab Method and means for preventing constriction of the pupil in the eye
MX9305615A (es) * 1992-09-14 1994-05-31 Walter P Smith Composicion para el acondicionamiento de la piel, su aplicacion y fabricacion.
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
US5543148A (en) * 1994-07-12 1996-08-06 Combe, Incorporated Stick delivery system for topical application of a treatment agent

Also Published As

Publication number Publication date
FR2729855B1 (hu) 1997-02-21
DE69611106D1 (de) 2001-01-11
HUP9600162A2 (en) 1997-01-28
US6019967A (en) 2000-02-01
FR2729855A1 (fr) 1996-08-02
JP3043608B2 (ja) 2000-05-22
EP0723774B1 (fr) 2000-12-06
DK0723774T3 (da) 2001-01-29
JPH08231434A (ja) 1996-09-10
CA2167980A1 (fr) 1996-07-27
PL184701B1 (pl) 2002-12-31
ATE197896T1 (de) 2000-12-15
ES2154388T3 (es) 2001-04-01
AR002023A1 (es) 1998-01-07
EP0723774A1 (fr) 1996-07-31
CA2167980C (fr) 2008-03-18
RU2180854C2 (ru) 2002-03-27
DE69611106T2 (de) 2001-04-05
HU9600162D0 (en) 1996-03-28
BR9600487A (pt) 1998-03-03
PL312481A1 (en) 1996-08-05

Similar Documents

Publication Publication Date Title
HUP9600162A3 (en) Use of an antagonist of cgrp in cosmetic, pharmaceutical or dermatological compositions and the cosmetic compositions
HUP0101137A3 (en) Anticoagulant amidines and their pharmaceutical use
HUP9601161A3 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
HK1112180A1 (en) Pharmaceutical use and compositions involving isoflavones
IL122464A0 (en) N-heteroaryl-pyridinesulonamide derivatives and their use as endothelin antagonists
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
BR9601478A (pt) Utilizações de ao menos um antagonista de CGRP composição cosmética farmacêutica e/ou dermatológica processo de tratamento cosmético de vermilhidões cutâneas e processo de tratamento cosmético de rosásea e/ou de eritema pudico
BR9609831A (pt) Composições cosméticas e/ou farmacêuticas antipruríticas
HUP9600256A3 (en) Substituted diphenyl-sulfonamide endothelin antagonists, pharmaceutical compositions containing the same and their medical uses
AU8905098A (en) Skin care compositions and use
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
HU9503624D0 (en) Use of p antagonist in pharmaceutical compositions
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
HUP0000873A3 (en) The use of levobupivacaine in facial surgery
ITMI913127A0 (it) Composizioni per uso dermatologico e cosmetico
BR9800753B1 (pt) composição cosmética e/ou dermatológica e uso de uma composição.
IL126734A0 (en) Cosmetic and/or pharmaceutical and/or dermatological compositions
EP0776657A3 (de) Kosmetische und/oder pharmazeutische Emulsionen
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
HUP9903526A3 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
HUP9801835A3 (en) Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
PL311915A1 (en) Pharmaceutic, dermatological and cosmetic composition
FR2724318B1 (fr) Composition cosmetique prevenant ou attenuant la photo-reactivite de manopigments de dioxyde de titane